Radiotherapy & Oncology
Volume 89, Issue 1 , Pages 38-43 , October 2008

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer

  • Charlotte L. Zuur

      Affiliations

    • Department of Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Charlotte L. Zuur, Department of Head and Neck Surgery, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, PO BOX 7057 1007 MB Amsterdam, The Netherlands.
    • ,
  • Yvonne J.W. Simis

      Affiliations

    • Department of Audiology, Academical Medical Centre Amsterdam, The Netherlands
    • ,
  • Roxanna S. Verkaik

      Affiliations

    • Department of Radiation Oncology The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • ,
  • Jan H. Schornagel

      Affiliations

    • Department of Medical Oncology The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • ,
  • Alfons J.M. Balm

      Affiliations

    • Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • Department of Otorhinolaryngology, Academical Medical Centre Amsterdam, The Netherlands
    • ,
  • Wouter A. Dreschler

      Affiliations

    • Department of Audiology, Academical Medical Centre Amsterdam, The Netherlands
    • ,
  • Coen R.N. Rasch

      Affiliations

    • Department of Medical Oncology The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 29 May 2007 ,Revised 4 June 2008 ,Accepted 18 June 2008.

References 

  1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779–4786
  2. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949–955
  3. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92–98
  4. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Eng J Med. 2004;350:1937–1944
  5. Vega de la FA, Vera Garcia R, Dominguez D, et al. Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas. Am J Clin Oncol. 2003;26:550–557
  6. Lau H, Brar S, Hao D, MacKinnon J, Yee D, Gluck S. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: analysis of survival and toxicity. Head Neck. 2006;28:189–196
  7. Beckmann GK, Hoppe F, Pfeundner L, Flentje MP. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck. 2005;27:36–43
  8. Jeremic B, Milicic B, Dagovic A, Vaskovic Z, Tadic L. Radiation therapy with or without concurrent low-dose daily cisplatin chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3540–3548
  9. Bartelink H, Bogaert van den W, Horiot JC, Jager J, Glabbeke van M. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial. Eur J Cancer. 2002;38:667–673
  10. Aguilar-Markulis NL, Beckly S, Priore R, Mettlin C. Auditory effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients. J Surg Oncol. 1981;16:111–123
  11. Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope. 1993;103:1–52
  12. Anteunis LJC, Wanders SL, Hendriks JJT, et al. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg. 1994;168:408–411
  13. Ho WK, Wei WI, Kwong DLW, et al. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study. Head Neck. 1999;21:547–553
  14. Kwong DLW, Wei WI, Sham JST, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Rad Oncol Biol Physiol. 1996;36:281–289
  15. Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol. 2002;65:1–7
  16. Oh YT, Kim CH, Choi JH, et al. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol. 2004;72:79–82
  17. Palazzi MP, Guzzo M, Tomatis S, et al. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Rad Oncol Biol Physiol. 2004;60:1451–1458
  18. Wang LF, Kuo WR, Ho KY, et al. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otol Neurotol. 2004;25:168–173
  19. Pan CC, Eisbruch A, Lee JS, et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Rad Oncol Biol Physiol. 2005;61:1393–1402
  20. Zuur CL, Simis YJW, Lansdaal PEM, et al. Ototoxicity in a randomized phase III trial of intra-arterial versus intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer; a multivariate analysis. J Clin Oncol. 2007;25:3759–3765
  21. Zuur CL, Simis YJW, Lansdaal PEM, et al. Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer. Audiol Neurotol. 2006;11:318–330
  22. Zuur CL, Simis YJW, Lansdaal PEM, et al. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol Biol Phys. 2007;68:1320–1325
  23. CRN Rasch, AJM Balm, JH Schornagel, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer, early results of a multi-institutional trial. ASTRO, 2006 (Abstract).
  24. Hoebers FJP, Heemsbergen W, Balm AJM, Zanten van M, Schornagel JH, Rasch CRN. Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma. Radiother Oncol. 2007;85:42–47
  25. Cancer Therapy Evaluation Programm, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003. Available from: http://ctep.cancer.gov. Publ. date: December 12, 2003.
  26. Dreschler WA, vd Hulst RJ, Tange RA, Urbanus NA. The role of high-frequency audiometry in early detection of ototoxicity. Audiol. 1985;24:387–395
  27. Zuur CL, Simis YJ, Lamers EA, Hart AA, Dreschler WA, Balm AJ, Rasch CR. Risk factors for hearing loss in head-and-neck cancer patients treated with Intensity-Modulated Radiation Therapy. Currently under review.
  28. Johannesen TB, Rasmussen K, Winther FO, Halvorsen U, Lote K. Late radiation effects on hearing, vestibular function, and taste in brain tumor patients. Int J Radiat Oncol Biol Phys. 2002;53:86–90
  29. Grau C, Moller K, Overgaard M, Overgaard J, Elbrond O. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1991;21:723–728
  30. Vermorken JB, Kapteijn TS, Hart AA, Pinedo HM. Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol. 1983;19:53–58
  31. Laurell G, Bagger-Sjöbäck D. Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol. 1991;20:158–167

PII: S0167-8140(08)00328-9

doi: 10.1016/j.radonc.2008.06.003

Radiotherapy & Oncology
Volume 89, Issue 1 , Pages 38-43 , October 2008

Article Tools

* Image Usage & Resolution